Avidity Biosciences
111 hedge funds and large institutions have $1.09B invested in Avidity Biosciences in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.52% more ownership
Funds ownership: 91.8% → 97.32% (+5.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
111
Holding in Top 10
1
Calls
$204K
Puts
–
Top Buyers
| 1 | +$112M | |
| 2 | +$40.5M | |
| 3 | +$19.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.5M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$16.1M |
Top Sellers
| 1 | -$29.7M | |
| 2 | -$25.5M | |
| 3 | -$13.8M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$10.5M |
| 5 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
-$6.38M |